Research And Development
R&D Capabilities
Since our inception, we have persistently expanded our activities in pharmaceutical R&D, consistently investing more resources into research projects. To achieve our vision and mission, we recruit highly specialized scientists to join our research team, which currently comprises over 40 members
At Sushen, we actively participate in various conferences, seminars, and training sessions in coordination with partner institutes. This ensures we stay updated with the latest pharmaceutical research and continually enhance the capabilities of our R&D team. Our R&D efforts are bolstered by these long-term associations with esteemed universities and educational institutes to carry out advanced research.
We focus on developing products in various pharmaceutical forms and combinations of multiple drugs to create significant benefits for patients. Our R&D team possesses extensive experience in developing over 80 innovative products across different categories, including cardiovascular, anti-diabetic, analgesic, anti-convulsant, bronchodilator, anti-platelet, and others. These developments utilize a wide array of equipment and technology.
Our R&D team has demonstrated its capabilities by successfully completing multiple bioequivalence studies.
Additionally, our team is proficient in transferring complete technology from R&D scale to production scale at Contract Manufacturing Organization (CMO) site.
Institutes Association
Simple Oral Dosage Forms
- Immediate Release (IR) tablets
- Oro-Dispersible and Chewable tablets
- Oral Solutions and Suspensions
- Hard Gelatin capsules
Complex Solid Dosage Forms
- Extended Release (ER) tablets/capsules
- Bi-layered tablets
- Multi-Particulate Controlled Release Capsules
- Gastro-Resistant or Delayed Release (GR/DR) tablets/capsules
- Effervescent Tablets/Sachets